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Introduction
The year of 2010 marks a centennial anniversary of the
description by Stella Starkel and Les³aw Wêgrzynows-
ki, Polish students of the Faculty of Medicine, Univer-
sity of Lwów, of the fetal zone in the human fetal adre-
nal gland [1]. Their investigations were performed in
the Institute of Pathological Anatomy. In 1911, both
Starkel and Wêgrzynowski were graduated from the
Faculty of Medicine of Lwow University. In the entire
scientific world the priority of their discovery is
unquestionable and their publication is still cited in
international literature. What did the study concern?
The paper appeared in the German Arch. Anat. Physi-
ol. and its original title was "Beitrag zur Histologie der
Nebeniere bei Feten und Kindern" ("Contribution to
histology of adrenals of fetuses and children"). Studies
were performed on 100 adrenal glands obtained from
fetuses (from 6th month of gestation) and up to 5-year-
old children. They described the fetal zone as a
"medullary zone", also as "immature cortex" which
undergoes involution in first years of life. Their origi-
nal drawning is shown (Fig. 1). They also noted that in
neonates the weight of human fetal adrenal gland
undergoes a rapid and notable decrease. Prof. Heinrich
Wilhelm Waldeyer, the editor of Arch. Anat. Physiol.
in his commentary stressed the importance and origi-
nality of the paper. Starkel and Wêgrzynowski had
also published their findings in Polish, in the Warsaw
medical journal, entitled "Medycyna and Kronika
Lekarska" (Medicine and Medical Chronicle) [2].
In 1961 H. Kuñski recalled this great discovery in
the Pol. Med. Sci. Hist. Bull. [3]. The centennial
anniversary of the first description of the human adre-
nal fetal zone also deserves a special recall and gives
an opportunity to present the most important findings
on the development of the human adrenal gland, in
particular its fetal zone.
An outline of the human adrenal development
Results of extensive studies on human adrenal gland
development allowed Sucheston and Cannon [4] to
divide this process into five phases: (i) condensation of
the celomic epithelium (3-4 weeks of gestation); (ii)
proliferation and migration of celomic epithelial cells
(4-6 weeks of gestation); (iii) morphological differen-
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tiation of fetal adrenal cortical cells into two distinct
zones (8-10 weeks of gestation); (iv) decline and dis-
appearance of the fetal zone (first 3 postnatal months);
and (v) establishment and stabilization of the adult
zonal pattern (10-20 yr of age) (Fig. 2).
Adrenal cortex morphogenesis starts at weeks 3-4
of intrauterine life with appearance of local thickening
of celomic epithelium, called also the adrenal anlage.
Subsequently, cells of the anlage migrate to the cranial
end of the mesonephros (weeks 4-6 of intrauterine
development) forming adrenal placode (adrenal
blastema) [5]. Also cells originating from the urogeni-
tal ridge (developing from the intermediate mesoderm)
migrate to adrenal placode, thus forming the adreno-
gonadal ridge. At this stage of development, expres-
sion of SF1 (steroidogenic factor 1 gene) takes place in
cells destined to become the steroidogenic cells of the
adrenals and gonads. Adrenal cortex originates from
the cephalic part of the adreno-gonadal ridge, while
steroidogenic cells of the gonads originate from its
caudal portion.
Around the developing adrenals, specialized mes-
enchymal cells migrating from the area of Bowman's
capsule form adrenal capsule (weeks 8-9 of intrauter-
ine development). At this stage of development neural
crest-derived cells migrate into the gland and they will
differentiate into medullary chromaffin cells. Numer-
ous islands of small, neural-crest derived cells, called
also as sympathogonias, are dispersed among the
steroidogenic cells, especially within the fetal zone. At
this stage of development steroidogenic cells are
organized into two distinct components. Centrally
localized cells, with abundant, eosinophilic cytoplasm,
form adrenal fetal zone, while small steroidogenic
cells with basophilic cytoplasm, form a very narrow
definitive cortex only in the vicinity of adrenal cap-
sule. Subsequently, the transitory (or intermediate)
zone differentiates from the definitive cortex. This
zone, localized in between definitive and fetal zones, is
composed of cells similar to that of the definitive zone.
Both definitive and transitory zones are also called the
neocortex (Figs. 3, 4). 
Origin of fetal and definitive zone cells of human
adrenal gland is controversial [6]. It had been suggest-
ed that they may originate from two distinct waves of
migrating celomic cells, or from the local differentia-
tion of a common progenitor cell. Some authors also
suggest that fetal adrenocortical cells originate from
two distinct types of progenitor cells – one specific for
the fetal zone and another for the neocortex.
As mentioned above, growth of fetal adrenals
depends mainly on enlargement of the fetal zone,
which may occupy 70-85% of the gland volume [7-
12]. Rich vascular supply of the fetal zone probably is
connected with the potent secretory activity of its cells.
At the end of gestation, a developing adrenal gland is
organized into distinct zones: glomerulosa, transitory
(appears between weeks 22-24, the future zona fascic-
ulata) and dominant fetal zone. Immediately after
birth, the fetal zone undergoes rapid involution, but its
elements may persist up to the end of the second year
of life [13,14]. In human adrenal gland zona reticularis
starts to develop at the age of 4-6 or even 8 years,
while structure typical to adults stabilizes at the age of
10-20 years [4,11,15,16].
Adrenal weight during human ontogenesis
Intrauterine growth of the human adrenal glands is
rapid and depends primarily on enlargement of the
fetal zone. From weeks 8-10 up to midterm their
weight doubles weekly. Subsequently, from week 20
to the term, adrenals weight increases from ca 0.5 g
to 8-10 g. Thus, this phase of adrenal growth is also
prominent, however its dynamics is lower than in the
first half of intrauterine development [7,11,13,17-
22]). At midgestation the size of adrenals is almost
equal to that of fetal kidneys and at term they are
similar in weight to adult adrenals (weight of both
glands averages at 8-10 g). Immediately after birth
adrenals undergo a physiologic involution (drop of
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Fig. 1. Original drawing of the human fetal adrenal gland from
Starkel and Wêgrzynowski (1910) [1]. Adrenal gland of "6-month-
old embryo. t – capsule; a – mature cortical cells; b – immature
cortical cells; sg – groups of sympathogonia".
weight to around 2 g), and only at the end of puberty
they again attain the size similar to that seen in the
newborns. At term, the relative adrenal weight is 10-
20- fold higher than that of the adult adrenals (Fig. 5).
In anencephalic fetuses, which do not secrete
ACTH, adrenal gland weight is notably lower than in
normal ones, and this difference starts to occur before
week 20 of intrauterine life [4,23,24].
Recently, a size of the fetal adrenal gland may be
evaluated ultrasonographically. Results of such studies
also prove a dynamic increase in adrenal gland weight
and their sudden involution in neonates [25-29].
Morphological aspects of human adrenal
gland development 
Histologic aspects. Since the first description of the
human adrenal fetal zone by Starkel and Wêgrzynows-
ki [1,2], numerous studies were performed on its
development, structure and function. A comprehensive
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Fig. 2. Outline of the development of the adrenal cortex. Factors implicated in regulating particular stages of adrenocortical development
are shown [data from analyses of human genetic diseases (capital letters) or mouse models (first letter capitalized)]. After: Else, T., Ham-
mer, G.D.: Genetic analysis of adrenal absence: agenesis and aplasia. Trends Endocrinol. Metab., 16: 458-468 (2005) [6] modified.
review of the earliest reports is presented in the excel-
lent monograph of Bachmann [13]. The original obser-
vations of the Polish students were confirmed in 1911
by Elliot and Armour [30]. Out of the earlier reports
on the subject, publications of Keene and Hewer
[31], Tobeck [32], Uotila [33], Swinyard [17], Veli-
can [34], [35], Lantan [36,37] and Wo³ynska [38]
should be mentioned. All of them provided detailed
cytological descriptions of developing adrenal gland.
Human adrenal fetal zone cells are large cells, with
eosinophilic cytoplasm and usually round nucleus.
They differ significantly from cells of the definitive
zone. Cells of the zone are small, with basophilic
cytoplasm with only few lipid droplets, thus they are
of the proliferative type.
Electron microscopy. In human adrenal fetal zone
electron microscopy revealed ultrastructural features
characteristic of all steroid-secreting cells. Results of
these studies were reviewed by Nussdorfer [39] and all
of them consistently described ultrastructural features
of the cells as well as their appearance in the course of
development. As early as from week 8 of intrauterine
life, fetal zone cells possesses an abundant smooth
endoplasmic reticulum, numerous mitochondria with
tubular cristae, well developed Golgi apparatus and
lipid droplets [40-48]. In contrast to fetal zone cells,
cytoplasm of cells of the definitive and transitory
zones contains numerous free ribosomes and small
mitochondria with membranous cristae. 
Of interest is that in cells of adrenal fetal zone of
anencephalic fetuses large number of lipid droplets,
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Fig. 5. Absolute and relative human adrenal gland weights during
intrauterine and postnatal life's. Absolute (circles) and relative
(black circles) adrenal weights. After Neville, A.M., O'Hare, M.J.:
The Human Adrenal Cortex. Springer-Verlag, Berlin, 1982 [174],
modified.
Fig. 3. General structure of the fetal adrenal gland at week 30 of
intrauterine life (left) and of adult man (right). DZ – definitive
zone; ZG – zona glomerulosa; TZ – transitional zone; ZF – zona
fasciculata; FZ – fetal zone; M – medulla. H+E staining. Magnifi-
cations shown by bars. Courtesy of dr. Maria Chmielnicka-
Kopaczyk, Department of Biochemistry and Pathomorphology,
Poznañ University of Medical Science. 
Fig. 4. Human adrenal fetal zone at week 30 of intrauterine life. In
fetal zone numerous differentiating chromaffin cells (SG – sympa-
thogonia) are seen. H+E staining. Magnifications shown by bars.
Courtesy of dr. Maria Chmielnicka-Kopaczyk, Department of Bio-
chemistry and Pathomorphology, Poznañ University of Medical
Science.
rough endoplasmic reticulum, tubular or vesicular pro-
files of smooth endoplasmic reticulum and mitochon-
dria with poorly developed cristae are seen [49].
Morphometry, stereology. Quantitative morphological
studies revealed notable changes in cellular and zonal
composition of the developing human adrenal gland.
The volume of adrenocortical cells showed correlation
with gestational age only in the definitive zone of the
developing adrenal, while in fetal zone cell volume
was rather stable, not related to pregnancy duration
[50]. Other studies revealed that from the beginning of
development, fasciculata cell volume (transitory zone)
was markedly higher than that of definitive zone cells
and lower than in fetal zone cells [8]. The average cell
volume of the definitive and transitory zones remained
constant during the fetal period, while the average cell
volume of fetal zone cells increased gradually from the
9th to the 20th fetal week and afterwards remained
unchanged. Also zonation of the fetal adrenals changes
notably during the intrauterine development. Gray and
Abramovich [24] reported that at midgestation in nor-
mal fetuses 76.5% of the gland volume was occupied
by the fetal zone. In other reports, at the end of fetal
period volume of fetal zone attained over 8200 mm3
and occupied 69-70% of the total gland volume, while
respective values for definitive and transitory zones
and medulla were 1665 mm3 (14%), 833 mm3 (7%)
and 1071 mm3 (9%) [8,9,51,52]). The above men-
tioned changes are accompanied by notable changes in
the number of adrenocortical cells. In normal fetuses,
at the end of gestation, the definitive zone (zona
glomerulosa) contains ca 3.5 × 109 cells, the transitory
one (presumptive zona fasciculata) 0.7 × 109 and the
fetal zone approximately 3 × 109 cells.
In anencephalic fetuses, due to the lack of fetal
ACTH, development of fetal adrenal is profoundly dis-
turbed. At midgestation, the volume of the adrenal gland
occupied by the fetal zone in the anencephalic fetuses
was 57.5%, as compared with 76.5% in normal fetuses
[24]. Systemic description of the development of adre-
nal gland of anencephalic fetuses, in comparison with
the normally developing gland, revealed that at the end
of gestation volume of the fetal zone is approximately 8-
fold lower than in the normal fetus, comprising only
25% of the total gland volume [9,51-53]. For the
remaining zones the values were: definitive zone – 1501
mm3 (around 90% of the normal value and 39% of the
total gland volume); transitory zone – 770 mm3 (around
92% and 20% respectively), and medulla – 539 mm3
(around 50% and 14%, respectively). Thus, in anen-
cephalic fetuses the growth of adrenal medulla is also
retarded while the growth of the definitive zone remains
rather unaffected. These changes depend on the pro-
found changes in the size and number of parenchymal
cells in developing human adrenal glands.
Histochemistry, immunohistochemistry, immunoflu-
orescence, in situ hybridization. Numerous publica-
tions on human adrenal fetal zone contain data on
localization of different cellular components in the
gland. Initially they were identified by means of classic
histological and histochemical methods, later on by
immunohistochemistry and finally by in situ hybridiza-
tion. In early period of those studies developing adrenal
glands were characterized in a rather general manner,
afterwards the studies were more selective and directed
preferentially toward the most important steroidogenic
enzymes (for example 3β-hydroxysteroid dehydroge-
nase – 3βHSD), growth factors and their receptors as
well as toward expression of genes regulating develop-
ment of the gland and adrenocortical steroidogenesis.
Aming the general studies important observations of
Jirasek [5] should be mentioned. He described localiza-
tion of numerous hydrolases, peptidases and dehydro-
genases in the human adrenal blastema. Similar studies
were performed by Lichnovský and Lojda [54] on
adrenals of fetuses from 8-20 weeks of gestation.
As far as elements of intracellular signaling path-
ways are concerned, during the second trimester of
gestation expression of αs subunit of the heterotrimer-
ic Gs protein was detected by immunofluorescence in
all adrenal cell types [55]. On the other hand, αi1-2
protein was restricted to the definitive zone, whereas
αi3 labeling was mainly expressed in the fetal zone.
Chromaffin cells of developing glands expressed αs,
αq, and αo1 subunits. Furthermore, the neocortex of
the fetal adrenal glands displayed only minimal StAR
immunostaining, whereas moderate to intense staining
was found in the transitory and fetal zones [56,57]).
Studies performed on 31 human fetal adrenal spec-
imens from weeks 14 – 40 of gestation revealed that
immunoreactivity for SF1 (Ad4BP) was present in the
nucleus of adrenocortical parenchymal cells in almost
all cells of the definitive, transitional and fetal zones in
all cases examined [57].
Series of publications present general characteris-
tics of steroidogenic enzymes in the developing human
adrenal gland [58-62]. Results of these studies suggest
that adrenals acquire the ability to synthesize and
secrete steroid hormones between weeks 6-8 of
intrauterine development. In developing adrenals
localization of such specific steroidogenic enzymes as
21-hydroxylase [62], 11β-hydroxylase [63], 11β-
hydroxysteroid dehydrogenase type 2 [64], 17α-
hydroxylase [65], and aldosterone synthase [66] has
also been described. Generally, activity of steroido-
genic enzymes and regulatory proteins is higher in the
fetal zone than in neocortex. 
Of special importance are studies on localization in
the developing human adrenal gland of the key
enzymes in particular steroidogenic pathways: 3β-
hydroxysteroid dehydrogenase/4-5 izomerase
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(3βHSD) and 17α-hydroxylase/17,20 lyase. Both
enzymes are required for cortisol synthesis. When only
3βHSD is expressed, cell possesses the ability to syn-
thesize mineralocorticoids, while expression of 17α-
hydroxylase/17,20 lyase only indicates synthesis of
C19 steroids, the androgens. In developing human
adrenal glands the main androgen involves dehy-
droepiandrosterone or its sulfate (DHEA, DHEAS). 
In a developing human adrenal gland localization of
3βHSD changes in relation to the stage of development
[11,57,67-74]). Analyses performed by Messiano and
Jaffe [11]indicate that human adrenal fetal zone, both on
mRNA and protein levels, does not express 3βHSD. In
that zone, however, 17α-hydroxylase/17,20 lyase com-
plex is present [65]. In the transitory zone of the gland
(the future zona fasciculata), expression of both
enzymes is found in weeks 25-30 of intrauterine life,
while in the definitive zone (zona glomerulosa) expres-
sion of 3βHSD appears between weeks 22 and 24. Since
functional data suggest fetal adrenal cortisol secretion
starting at weeks 6-8 of development [75], such a late
expression of 3βHSD is difficult to understand. One of
explanations may be, that in the human fetal adrenal
gland cortisol is not synthesized de novo from choles-
terol but from progesterone.
Another topic of studies on human fetal adrenal
gland focuses on the search for specific markers of
cells in particular zones of the gland. Identification of
such markers could help to obtain zone-specific frac-
tions of adrenocortical cells [76,77]. Such specific
markers of adrenocortical cells have not been found
yet. In definitive zone cells a high levels of metal-
lopanstimulin-1, novH (human nephroblastoma over-
expressed (novH) gene) and p-glycoprotein mRNA are
present, while in fetal zone the low density lipoprotein
(LDL) receptor is predominantly expressed. As
expected, chromogranin A is a typical marker of devel-
oping chromaffin cells.
Quantitative aspects of steroidogenic path-
ways in neocortex and fetal zone of the human
adrenal gland 
Introduction of modern techniques expanded our
knowledge of steroidogenic pathways in developing
adrenals and on their regulation. In this regard appli-
cation of cell cultures of definitive and fetal adrenal
zones revealed significant functional differences
between them. This section presents some of such
data, obtained using quantitative methods. 
Considering steroidogenic pathways, the adrenal
fetal zone carries a higher number of LDL-binding
sites than definitive zone does and in both zones
ACTH stimulates LDL-binding [78,79]. Similar dif-
ferences are observed in de novo cholesterol synthesis
and, again, ACTH stimulates this synthesis. 
Out of corticosteroidogenesis regulating intracellu-
lar pathways, basal adenylate cyclase activity is 2- to
3-fold higher in definitive zone than in fetal zone
membrane fractions [80]. In adrenals of anencephalics,
the basal adenylate cyclase activity is reduced to 3-5%
of that observed in normal adrenals [81]. Likewise, the
specific activity of protein kinase-C and the amount of
kinase-C protein are significantly higher in fetal zone
than in definitive zone, while they are very low in
adrenals of anencephalic fetuses [82].
Cholesterol desmolase (CYP11A1, the enzyme
responsible for transformation of cholesterol into
pregnenolone) activity, is 3-4-fold higher in the fetal
zone than in the definitive one. Activity of this
enzyme is also present in adrenals of anencephalic
fetuses [83]. As mentioned earlier, special attention in
these studies has been focused on 3βHSD activity in
developing human adrenal. In this regard, in cultures
of fetal zone and definitive zone cells of human fetal
adrenal, 3βHSD expression cannot be detected until
ACTH is added. ACTH induces the 3βHSD type II
activity and mRNA expression. A higher level of
3βHSD mRNA is present in definitive zone compared
with fetal zone cells [72]. 
As far as mineralocorticoid synthesis is concerned,
using the RNase protection assay, aldosterone synthase
(CYP11B2) mRNA is observed in the RNA from the
neocortex, while RT-PCR reveals the presence of
CYP11B2 mRNA in both neocortex and fetal zone
[63,66]. Also notable differences between neocortex
and fetal zone are seen in sulfotransferase activity. The
highest rate of sulfurylation of pregnenolone and
DHEA is found in the cytosol of the fetal zone (5 nmol
min-1 mg protein-1). The corresponding activities in
fetal neocortex, anencephalic, and adult adrenocortical
tissues amount to one tenth of that in the fetal zone
[83].
Steroidogenesis in the developing human
adrenal gland
Human fetal adrenal is a highly steroidogenic organ.
For most of gestation, fetal zone secretes large quanti-
ties of DHEA and DHEAS, attaining the production
rate of up to 100-200 mg/day. The rate of steroid secre-
tion by the fetal adrenals may be 5-fold higher than
that by the adrenals of adults at rest [78]. Functional
data indicate cortisol and DHEAS secretion as early as
at weeks 6-8 of gestation, while aldosterone secretion
starts after weeks 20-24 [11,75].
The earliest studies on steroidogenic capacity of
developing human adrenal gland were based on identi-
fication and quantitation of steroids in extracts of the
gland, in cord blood and amniotic fluid. Subsequently,
adrenal slice or homogenate assays demonstrated in
fetal adrenals the presence of enzyme systems required
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to convert acetate to steroids [for review see 19,84,85].
Initial studies also revealed responsiveness of the
human fetal adrenal cortex to ACTH [86-89]. Further-
more, early studies documented a lowered steroid pro-
duction by adrenals of anencephalics [90-92].
Introduction of cell cultures further expanded our
knowledge on steroid secretion by definitive and fetal
zone cells. The studies demonstrated cortisol secre-
tion by neocortex and DHEA/DHEAS by fetal zone
as well as stimulating effects of ACTH on their secre-
tion [93-101].
A general agreement has been reached that in cord
blood from human fetuses between 10 and 20 weeks of
gestation, concentrations of cortisol, aldosterone and
DHEA/DHEAS are higher in the umbilical artery than
in the umbilical vein, indicating that these steroids are
produced by the fetus [11,102-106]. As expected, low-
ered corticosteroid levels are present in fetal blood of
anencephalics [106,107].
Cortisol and DHEA/DHEAS secretion by fetal
adrenal is well recognised and the findings leave no
doubts. However, more questions concern aldosterone
synthesis. Aldosterone has been isolated from human
fetal adrenal glands as early as in 1956 [108]. Subse-
quent perfusion experiments revealed that the gland is
capable of converting progesterone to aldosterone
[87,109]). Moreover, the aldosterone concentration in
fetal plasma is 2-12 times higher than that in the cor-
responding mothers [110,111]. Early in gestation min-
eralocorticoid production by the human fetal adrenal
cortex is very low but it increases during the third
trimester. Its concentration in human amniotic fluid
also increases markedly from the weeks 14-16 of ges-
tation till term [112,113]. Human fetal adrenal aldos-
terone biosynthesis was confirmed by means of tissue
culture studies [114]. Later it was found that subcap-
sular region of the fetal adrenal is the main source of
this hormone [97]. Aldosterone synthesis by definitive
zone of human fetal adrenal was confirmed in subse-
quent publications [11,115].
Proliferative activity of fetal adrenocortical
cells and apoptosis
It is well known that mutual interrelationship between
cell proliferation and their elimination, primarily via
apoptosis, governs growth and patterning of develop-
ing adrenal gland. 
In adult adrenal gland proliferating cells are
observed primarily in the subcapsular region of adrenal
cortex. In this regard, in 1883 Gottschau [116] intro-
duced a hypothesis on centripetal migration of adreno-
cortical cells from the subcapsular region into the center
of the gland (zona reticularis), where parenchymal cells
undergo elimination [13]. This hypothesis is confirmed
by the recently applied molecular biology techniques,
the results of which suggest clonal centripetal migration
of adrenocortical cells [117].
Centripetal migration of cells from the definitive
to the fetal zone was also observed in the developing
human adrenal gland [5,7,31]. The earliest reports
have based primarily on the observation of dividing
cells in the glands. Introduction of immunohisto-
chemistry extended these observation. In the earliest
periods studied (weeks 6-8 of intrauterine develop-
ment) proliferating-cell nuclear antigen (PCNA) pos-
itive cells were observed in the central part of devel-
oping fetal zone while the peripheral part was
immunonegative. At week 8 of development, both
definitive and fetal zones exhibited similar prolifera-
tive activity. At this stage of development the middle
proliferative center of the fetal zone disappeared, and
all cells of this zone had similar PCNA reactivity
[118]. In other studies PCNA-immunopositive cells
were observed only in the narrow surface zone of the
primitive adrenal cortex [119,120]. Proliferation of
fetal adrenal cells from 12 to 25 weeks of develop-
ment was also assessed by PCNA and Ki-67 method
[62]. PCNA and Ki-67 immunopositive cells were
visible only in cells of the definitive zone and index-
es of proliferation from 40% and 25% respectively,
decreased gradually and were lower than 1% at the
25th week of intrauterine life. Similar studies (from
10 to 25 week of development) revealed that between
weeks 10-14, PCNA indexes were similar in defini-
tive and fetal zones of the gland and increased signif-
icantly between weeks 15-20 of gestation [121]. After
14 weeks, the mitotic index of the definitive zone was
higher than that of fetal zone (approximately 59% vs.
39%). Despite the variable results, these studies sug-
gest that adrenocortical cells proliferate in the defin-
itive zone and migrate centripetally to form the fetal
zone [11].
There are several descriptions of apoptosis in
developing human adrenal gland. At all stages of ges-
tation apoptotic nuclei were not observed in the defin-
itive zone of developing adrenal. Only scattered apop-
totic nuclei were seen in central part of the fetal zone
and their number increases with the length of gestation
[121,122]. In postnatal period, apoptotic index of fetal
zone cells was highest during the second week of life,
and subsequently declined (from ca 30% to 20%)
[14,16,123].
Involution of the fetal zone
As mentioned, during two weeks after birth, the fetal
zone of human adrenal cortex practically disappears,
however fragments of the zone may persist in the
adrenals till the end of the 2 year of life [13,14,124]. It
is worth to emphasize marked individual variations in
the rate of involution of that zone. 
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The sudden postnatal involution of the fetal zone is
connected with notable hemorrhagic lesions and the
entire process may be divided into 2 distinct phases, the
rapid one, lasting from the birth till the end of the sec-
ond week of life, followed by a slower one [14,123]. As
revealed by stereology, this decrease is highly correlat-
ed with the decrease of both the volume of fetal zone
and quantity of its cells. During the first two weeks of
postnatal development, volume of the fetal zone
decreases from ca 70% to 3% of total adrenal volume
and the quantity of its parenchymal cells from around
40% to 5% of all parenchymal cells. Furthermore, the
volume of fetal zone stroma (connective tissue and
blood vessels) expands notably during the first day of
postnatal life and decreases from day 5th onward.
Factors regulating human fetal adrenal
growth and steroidogenesis
It is well known that ACTH secreted by the fetal pitu-
itary gland is a major factor regulating growth and
steroidogenic capacity of the human adrenal fetal zone
[11,125]. In congenital malformations connected with
the absence of pituitary gland, for example anen-
cephaly, development of the fetal zone is severely
impaired. In anencephalics fetal zone development is
comparable to that seen at 15-16th week of gestation
[4,9,23,24,51-53,126]. 
Rapid postnatal involution of the fetal zone indi-
cates that ACTH is not a sole factor regulating this
zone and maintaining its structure and function. More-
over, not gestational age but parturition itself is the
basis for fetal adrenal involution [29]. This implicates
that placental factors are also involved in maintaining
the fetal adrenal. And in fact, numerous factors have
been identified that affect growth and function of the
fetal zone during intrauterine life. These factors may
act independently from, or in concert with, ATCH.
Some of those factors are mentioned below.
Placental factors
hCG (human chorionic gonadotropin) extracted from
pregnancy urine, but not highly purified one, stimu-
lates thymidine incorporation into cultured fetal zone
cells and does not affect DHEA/DHEAS output
[97,127,128]. These findings suggest that the extract-
ed hCG contained an unidentified compound stimu-
lating cultured cells.
CRH (corticotrophin releasing hormone) is pro-
duced also by the placenta. In cultured fetal adreno-
cortical cells CRH stimulates all elements of DHEAS
synthetic pathway [129-133].
ACTH is also produced by human placenta [134-
137]. However, ACTH is not a growth factor per se
and in vitro inhibits proliferation of adrenocortical
cells. On the contrary, in vivo ACTH stimulates initial-
ly hypertrophy and later on mitotic activity of adreno-
cortical cells and possibly this effect may be mediated
by growth factor(s) [11,138].
Growth factors and neuropeptides
IGF-I and IGF-II (insulin-like growth factor) stimulate
proliferation of fetal adrenal cortical cells in a dose-
dependent fashion [11,59,60,139,140]. Authors sug-
gest that IGF-II may act as a mediator, in concert with
bFGF and possibly EGF, of the tropic action of ACTH
in induction of the rapid growth of the human fetal
adrenal cortex during midgestation. It is believed that
IGF system is the most important controller of fetal
zone growth.
EGF (epidermal growth factor) stimulates thymi-
dine incorporation into cultured fetal zone cells and
has no effect on DHEA secretion [128].
bFGF (basic fibroblast growth factor) stimulates
proliferation of both fetal and definitive zone cells
[141-143].
Midkine (heparin-binding growth factor) selective-
ly stimulates proliferation of definitive zone cells of
the human fetal adrenal gland [144].
TNF (tumor necrosis factor) inhibits the ACTH-
induced production of cortisol in cultures of human
fetal adrenals [71,114]. These results show that TNF
suppresses the synthesis of cortisol and shifts the
steroid secretory pattern towards androgen production.
Activin A inhibits proliferation of cultured human
fetal adrenal cells [145,146].
TGF-beta (transforming growth factor beta) dose-
dependently inhibits the growth of fetal neocortical
cells, an effect partially prevented by ACTH [146-
152]. Of interest is that in the fetal zone, ACTH and
TGF-beta have additive inhibitory effects on cell pro-
liferation.
GH (growth hormone) and beta-lipotropin inhibits
DHEAS secretion by cultured fetal zone cells [97]. 
ANP (atrial natriuretic peptide) inhibits basal and
ACTH-stimulated steroid secretion by fetal zone
cells [153]. The inhibitory effect of ANP on fetal
steroidogenesis depends on inhibition of cholesterol
side chain cleavage or transfer of cholesterol to the
mitochondria.
PACAP (pituitary adenylate-cyclase activating
peptide) significantly increases cortisol and DHEAS
secretion by cultured fetal adrenal cells [154-156].
Nuclear receptor/transcription factors
A growing body of literature demonstrates the role of
transcription factors in regulating development of the
adrenal gland. However, experimental data are only
available for animals [6,157,158]. 
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Analyses of inherited disorders suggest that some
transcription factors are also involved in the develop-
ment of human fetal adrenals (Fig. 2). One of such fac-
tors is GLI3 (GLI family zinc finger 3). Mutations in
this transcription factor are causing Pallister-Hall syn-
drome and in some patients with this syndrome
absence or hypoplasia of the adrenal glands were
reported [159,160]. 
Also mutations of DAX1 [dosage-sensitive sex
reversal congenital adrenal hypoplasia (AHC), a criti-
cal region on the X chromosome] were originally
found in patients with the cytomegalic form of AHC.
AHC combines two distinct histological patterns in the
adrenal cortices, the miniature adult and cytomegalic
forms. In the miniature adult form of AHC, the small
amount of residual adrenal cortex is composed prima-
rily of permanent adult cortex with normal structural
organization. In the cytomegalic form of AHC, the
residual adrenal cortex is structurally disorganized
with scattered irregular nodular formations of
eosinophilic cells, with the adult permanent zone
absent or nearly absent [158,161]). This inherited dis-
order is commonly manifested as an early-onset adre-
nal insufficiency syndrome [162-164].
Recently Achermann et al. [165] suggested that
mutations in SF1 (steroidogenic factor-1 or Ad4BP)
result in adrenal failure in humans.
Data from global gene profiling
Modern global gene profiling study revealed numer-
ous novel factors associated with the development or
differentiated function of the adrenal cortex. By DNA
microarrays, Rainey et al. [166] compared expression
levels of several thousand transcripts (from 7075 to
9182 cDNA elements) between the human fetal and
adult adrenal gland. Out of them, 69 transcripts were
found to have a greater than 2.5-fold difference in
expression between fetal and adult adrenals. The
most pronounced differences were found for IGF-II
(25-fold higher expression in fetal adrenals) and
3βHSD (24-fold higher expression in adults). Gener-
ally, expression of genes connected with growth,
development and steroid biosynthesis was higher in
fetal adrenals. In adult adrenals, on the other hand,
the higher expression of genes connected to cellular
immunity and signal transduction pathways was
found. It remains, however, important that the vast
majority of the 69 transcripts have not been studied
with regard to adrenal function. Some of these data
were detailed in the subsequent study [167]. DHEA
sulfotransferase transcript (SULT2A1) was present at
13-fold higher levels in the fetal than the adult adren-
als. 3β-Hydroxysteroid dehydrogenase type II
(HSD3B2) mRNA was 127-fold higher in the adult
adrenal gland while StAR, 21-hydroxylase, 11β
hydroxylase, and aldosterone synthase mRNA abun-
dance did not differ significantly. 
The fetoplacental unit
As mentioned earlier, during most of gestation the fetal
adrenal gland secretes large amount of DHEAS, which
is used by the placenta to produce estrogens. These
observations led Diczfalusy [168-172] to introduce the
idea of a single endocrine steroidogenic unit of those
two organs, the fetoplacental unit. Early studies
revealed distinct variations in the pattern of steroido-
genic enzyme distribution in fetal adrenal and placenta.
In some instances, enzymes absent from one tissue are
present in another, so that fetus and placenta together
can synthesize steroids which they could not synthesize
in separation. Some of the steroid hormones, partly
metabolized in the placenta, are passed to the fetus for
modification; others originate in the fetal adrenal gland
and act as precursors for hormones that can be syn-
thetized by the placenta. The human placenta does not
produce estrogens de novo from cholesterol and cannot
convert pregnenolone or progesterone into C19 steroids
because it lacks the enzyme of 17α-hydroxylase/17,20
lyase (CYP17). Therefore, placenta produces estrogens
by aromatization of the C19 precursors, namely DHEA
and the 16α-hydroxy-DHEA (16-OH-DHEA), which
are synthesized predominantly in the fetal adrenal and
liver, respectively. In placenta they are aromatized to
estradiol, estrone and estriol [173]. It is of interest that a
similar fetoplacental steroidogenic unit is not present in
most other species [174].
Conclusions
The year of 2010 marks the centenary of the first
description of the human adrenal fetal zone. This tran-
sitory zone still intrigues world scientists. Despite
extensive investigations, the origin, development,
growth and steroidogenic function of the human adre-
nal fetal zone is not fully recognized. Notable progress
has been made in understanding zonal and cellular
composition of the gland. Also mechanisms of
steroidogenesis, including the feto-placental unit, and
their regulation are rather well known. With advance
of the modern techniques of molecular biology and
molecular engineering, future studies will likely be
directed into the regulatory mechanism of expression
of genes governing the development of the human fetal
adrenal gland. In this regard, global gene profiling by
Rainey et al. [166] has opened a new field of investi-
gations. Identification of numerous genes not previ-
ously known to be associated with the development or
specialized function of the human adrenal cortex, with
great probability will rapidly expand our understand-
ing of these processes.
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Addendum
Stella Maria Starkel (married name 
Wêgrzynowska) (1885 – 1969)
Stella Maria Starkel was born on August 10, 1885 in
Lwów. Her grandfather, Józef Cyryl Starkel (1807-
1876) was an esteemed physician, deeply involved in
life of the city of Tarnów, Eastern Poland. Her father,
Romuald Starkel (1850-1888), was a teacher and jour-
nalist. Starkels' mother, W³adys³awa Boczkowska, was
married to widower Romuald Starkel, with 12-year-
old daughter Maria. This marriage gave two daughters
– Stella and Janina and son W³adys³aw. Despite pover-
ty caused by premature death of Romuald, all children
completed University education [175]. 
Since at that time there were no schools for girls,
Stella Starkel home schooled. In 1904 she started
medical studies at Faculty of Medicine, Lwów
University (Fig. 6). It is worth to mention that at that
time only 2 girls were students of the Faculty of
Medicine. During studies, together with Les³aw
Wêgrzynowski, her future husband, she worked in
the Institute of Pathological Anatomy, where as first
in the world they described human adrenal fetal
zone. In 1911 both received diplomas of "doctor
medicinae universae".
During the World War I she became engaged in
dentistry [176]. She also worked, together with her
husband, Les³aw Wêgrzynowski, in military hospital
and field laboratories in Moravian Brno. After World
War I she worked in the laboratory of the SPROVAC,
serum and vaccine factory owned by her husband. 
After World War II Stella Wêgrzynowska worked
in laboratories of the Antituberculosis Sanatorium in
Bukowiec, near Kowary and Oborniki Œl¹skie.
Stella Maria Wêgrzynowska died on April 7, 1969
in Oborniki Œl¹skie, near Wroc³aw, Poland.
Les³aw Wêgrzynowski (1885-1956)
Les³aw Wêgrzynowski was born on September 17,
1885, in Rohatyn (Western Ukraine, not far from
Lwów) to the family with long patriotic and medical
traditions. His father, W³adys³aw, was a physician
while mother – Zofia Gluziñska – also grow up in
famous physicians' family.
In 1904 he received the general certificate of edu-
cation and started medical studies at the Faculty of
Medicine, Lwów University. During medical school
together with Stella Starkel, his future wife, he worked
in the Institute of Pathological Anatomy, where as first
in the world they described human adrenal fetal zone.
In 1911 both received diplomas of "doctor medicinae
universae".
After graduation he became interested in pneumo-
phthisiatric diseases, especially in lung tuberculosis
(TB). For 2 years he studied bacteriological and sero-
logical as well as clinical aspects of TB in the world-
known clinics of prof. F. Krause and Robert Koch
Institute (Berlin), dr. L. Brauer (Hamburg) and dr. Tur-
ban (Davos, Switzerland). After return to Lwów,
Wêgrzynowski worked in the Institute of Pharmacolo-
gy, at that time chaired by prof. Lech Popielski. 
In 1914 he became a chief of sanitary service of the
Polish Eastern Legion (Polish armed forces created in
August 1914 in Galicia, the southern district of
Poland) [176,177]. The Legion was disbanded on 21
September 1914 and Wêgrzynowski was taken to Aus-
trian army. He was a chief of military hospital and field
laboratories in Moravian Brno. At that time he had
worked together with his wife, Stella from Starkels'.
Since 1918 he served in the Polish Army. During the
Polish – Ukrainian war Wêgrzynowski headed the san-
itary service of the Main Command of the Lwów
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Fig. 6. Stella Starkel. From: Wêgrzynowska [175]. Fig. 7. Les³aw Wegrzynowski. From: Domos³awski [177].
Defence forces. After the war he was even the chief of
the board conferring Lwów Defence Cross. 
After the World War I Wêgrzynowski was employ-
ee of the Lwów University and developed his interest
in pneumo-phthisiatric diseases. Up to 1939 he was a
chief of the Outpatient TB Department in Lwów and of
Antituberculosis Sanatorium in Ho³osko Wielkie by
Lwów. At the beginning of the World War II he served
in the sanitary command of the Lwów, later on (up to
1941) he was nominated by Soviets as chairman of the
Lwów Phthisiatric Clinic of the Kijow Institute of
Tuberculosis. Arrested by Soviets, he avoided death
only, because somebody informed them that in 1914,
when Lenin was in Poronin and Cracow (Poland)
Wêgrzynowski treated him (two available sources
cited this fact). After entering of German forces to
Lwów, Wêgrzynowski and his family moved to
Warszawa. In Warszawa he worked as a physician and
participated in conspiracy activities. He was a consult-
ant to Ujazdowski Hospital and chief of the Antituber-
culosis Sanatorium in Œwider (near Warszawa).
In conspiracy he was functioning in the Govern-
mental Delegation for Poland (of the Polish Govern-
ment in Exile, London) saving the life of numerous
Jews. He had hided them in his clinics as a patients
while they waited further placement. Followed by
Gestapo, he went underground and took the pseudo-
nym of Bartosz. During the Warsaw Uprising Bartosz
served as the head of sanitary service of the I District
Warszawa Œródmieœcie of the Polish Home Army [see
the www page 178].
After World War II he restarted a function of the Pol-
ish Red Cross Sanatorium in Zakopane. Between years
1946 – 1947 he was director of the Antituberculosis
Sanatorium in Bukowiec, near Kowary and a cofounder
of the Polish Society of Studies on Tuberculosis.
On August 9, 1949 Wêgrzynowski became
employed as a deputy professor in the Department of
Phthisiatry, Faculty of Medicine, Wroc³aw University
(later on Medical Academy) [176,177]) (Fig. 7). As a
victim of the Secrete Police action (code name
"Medicine") [179] he was dismissed in 1951. Until the
end of his life he worked in the Municipal Antituber-
culosis Outpatient Clinic in Wroc³aw. He died in there
on June 10, 1956.
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